
GMT Id S.A.
Research and experimental development in natural sciences and engineering
Overview
Gmt Id is the creator of a mobile platform for genetic diagnostics called Genomtec ID, designed for point-of-care testing. The company has obtained a CE-IVD Mark for its GenomtecID Respiratory Panel 5-Plex, which detects viruses and bacteria responsible for respiratory tract infections, making it the only solution of its kind in Europe. Additionally, Genomtec is preparing for technology trials in Asia as part of its ongoing M&A efforts.
Financials
From the notes
| Current income tax (CIT due) | $0 | |
| Profit allocation | Loss to be covered | |
| Grants | $37,578 | |
| Deferred tax liability | $174 | |
| Merger or transformation | Yes | |
| Related parties | 2 items |
Filing timeliness
1 of 1 financial statements was filed late (for 2025, 62 days late). All were audited by a statutory auditor.
- 202515/09/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News

Miron Tokarski to speak at the upcoming webinar "Meeting the Challenges and Unlocking the Potential of Point-of-Care Molecular Diagnostics"

Another patent granted. Another step in building global protection for Genomtec's molecular diagnostics technology

Genomtec secured PLN 11 million from a share issue to finalise its global M&A strategy and commercialise the breakthrough Genomtec ID and OncoSNAAT® technologies

Launch of a public offering of Genomtec shares to raise funds for finalising the M&A process and commercialising Genomtec ID and OncoSNAAT® technologies

Genomtec plans a share issue. Proceeds will support the M&A process and the commercialisation of projects. The company has signed an investment agreement with a key shareholder.

As part of the M&A process, Genomtec is preparing to test its technology with potential partners in Asia
Industry
Offer
- Diagnostic equipment
- Molecular diagnostics kit
- Diagnostic tests
- Genetic diagnostics
Websites
The site is available in: Polish and English. The site targets these markets: United States.
- genomtec.comStrona główna - GenomtecWordPress 6.9Yoast SEOWWPMLApache
Job offers
The company lists many job openings on its own careers page: genomtec.com/o-nas. The first ones are below.
Authorized Representatives
Manner of representation
The company is represented by each member of the management board independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 600,000 | $162,074.55 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-11-01.
21 1090 2398 0000 0001 6186 7081
09 1090 2398 0000 0001 6186 7103
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-10-15 | Development of mobile diagnostic equipment based on a lab-on-chip solution for detecting COVID-19 (SARS-CoV-2 virus) | $1.7M$1,651,274 | Operational Programme Smart Growth | |
| 2019-01-01 | Development of technology and mobile diagnostic equipment based on a lab-on-chip solution for detecting infectious diseases | $2.3M$2,282,737 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Envcheck sp. z o.o. | $263,693.85 | envcheck.com | ||
| Vitrotest Europe sp. z o.o. | $233,350.77 | vitrotest.pl | ||
| Radialtec Poland sp. z o.o. | $165,016.64 | radialtec.net | ||
| Kamika Instruments sp. z o.o. | $114,049.10 | kamika.pl | ||
| Bacteromic sp. z o.o. | $112,732.71 | bacteromic.com | ||
| Replicon sp. z o.o. | $50,379.75 | replicon.pl | ||
| Amplicon sp. z o.o. | $48,330.99 | amplicon.pl | ||
| Spectra-Laser sp. z o.o. | $19,563.74 | spectra-laser.pl | ||
| V-Lab sp. z o.o. | $16,594.61 | vlab.com.pl | ||
| Nucleotica sp. z o.o. | $5,315.32 | nucleotica.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-11 | Share capital increase (100,000.00 PLN → 600,000.00 PLN) | |
| 2025-05-21 | Entered in the register |
FAQ
Last updated: 2026-09-15